Physician profile
Eric R Beyer
NPI 1750713806
$3,676.41
in general payments reported to CMS, 2019-2025
21 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $139 · 2021: $1,591 · 2022: $447 · 2023: $501 · 2024: $410 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.35 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,375.10 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $518.53 | 2019-2025 | Cequa |
| Alcon Vision LLC | $418.74 | 2021-2025 | Rocklatan, Eysuvis, Clareon |
| Bausch & Lomb Americas INC. | $278.32 | 2022-2025 | Miebo, Lotemax Sm, Vyzulta |
| Allergan, INC. | $204.39 | 2019-2021 | |
| Abbvie INC. | $139.36 | 2022-2024 | Vuity, Durysta, Lumigan |
| Oyster Point Pharma, INC. | $110.42 | 2022-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $94.14 | 2019-2023 | |
| Dompe US, INC. | $88.54 | 2022-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $77.34 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $61.97 | 2019-2021 | |
| Harrow Eye, LLC | $49.40 | 2024-2025 | Vevye |
| Biotissue Holdings INC. | $47.70 | 2021-2023 | |
| Mallinckrodt Hospital Products INC. | $43.85 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $38.15 | 2025 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $37.64 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $33.40 | 2025 | Tecnis Iol, Tecnis Iol |
| Glaukos Corporation | $17.63 | 2022 | |
| Aerie Pharmaceuticals, INC. | $14.38 | 2019 | |
| Shire North American Group INC | $14.25 | 2019 | |
| Thea Pharma INC. | $13.16 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Beyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.